The trial showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival.

Dow Jones Newswires: GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint
by
Tags:

The trial showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival.
by
Tags: